FFCP PHASE1:Mm9::chr6:113860572..113860579,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=11941|HGNC=|MCL_coexpression_id=37|UniProt=|association_with_transcript=0bp_to_ENSMUST00000144507_5end|description=CAGE_peak_12_at_Atp2b2_5end|id=chr6:113860572..113860579,-|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0003100!5.06e-41!11;UBERON:0001911!3.19e-26!2;UBERON:0000076!3.19e-26!2;UBERON:0005333!3.19e-26!2;UBERON:0008425!3.19e-26!2;UBERON:0005311!3.19e-26!2;UBERON:0000474!1.27e-22!9;UBERON:0003134!1.17e-14!8;UBERON:0000993!4.85e-14!1;UBERON:0006834!1.55e-13!1;UBERON:0005795!2.08e-13!4;UBERON:0000995!2.08e-13!4;UBERON:0007023!3.41e-12!51;UBERON:0003975!6.27e-11!5;UBERON:0005156!3.66e-08!26;UBERON:0000990!3.66e-08!26;UBERON:0001896!2.35e-07!2;UBERON:0005290!2.35e-07!2;UBERON:0010096!2.35e-07!2|ontology_enrichment_uberon_v019_2=UBERON:0001911,4.55e-44,2;UBERON:0000076,4.55e-44,2;UBERON:0005333,4.55e-44,2;UBERON:0008425,4.55e-44,2;UBERON:0005311,4.55e-44,2;UBERON:0003100,3.07e-32,11;UBERON:0000993,5.07e-23,1;UBERON:0000474,1.01e-10,9;UBERON:0005085,9.70e-08,13;UBERON:0007023,1.20e-07,51|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.6705709207614,1.10374698521893,0.160550589987792,0,0,0,0,0,0,0,0,0,0,0,0,0,0.283880170416537,0,0,2.63952196756057,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.187682475451182,2.38097111547445,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p12@Atp2b2}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=11941 | |||
|HGNC= | |||
|MCL_coexpression_id=37 | |||
|TSSclassifier=NA | |||
|UniProt= | |||
|association_with_transcript=0bp_to_ENSMUST00000144507_5end | |||
|cluster_id=chr6:113860572..113860579,- | |||
|description=CAGE_peak_12_at_Atp2b2_5end | |||
|id=chr6:113860572..113860579,- | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0003100!5.06e-41!11;UBERON:0001911!3.19e-26!2;UBERON:0000076!3.19e-26!2;UBERON:0005333!3.19e-26!2;UBERON:0008425!3.19e-26!2;UBERON:0005311!3.19e-26!2;UBERON:0000474!1.27e-22!9;UBERON:0003134!1.17e-14!8;UBERON:0000993!4.85e-14!1;UBERON:0006834!1.55e-13!1;UBERON:0005795!2.08e-13!4;UBERON:0000995!2.08e-13!4;UBERON:0007023!3.41e-12!51;UBERON:0003975!6.27e-11!5;UBERON:0005156!3.66e-08!26;UBERON:0000990!3.66e-08!26;UBERON:0001896!2.35e-07!2;UBERON:0005290!2.35e-07!2;UBERON:0010096!2.35e-07!2 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001911,4.55e-44,2;UBERON:0000076,4.55e-44,2;UBERON:0005333,4.55e-44,2;UBERON:0008425,4.55e-44,2;UBERON:0005311,4.55e-44,2;UBERON:0003100,3.07e-32,11;UBERON:0000993,5.07e-23,1;UBERON:0000474,1.01e-10,9;UBERON:0005085,9.70e-08,13;UBERON:0007023,1.20e-07,51 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.6705709207614,1.10374698521893,0.160550589987792,0,0,0,0,0,0,0,0,0,0,0,0,0,0.283880170416537,0,0,2.63952196756057,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.187682475451182,2.38097111547445,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p12@Atp2b2 | |||
}} |
Latest revision as of 11:43, 26 September 2015
Short description: | p12@Atp2b2 |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_12_at_Atp2b2_5end |
Coexpression cluster: | MCL_coexpression_mm9:37 |
Association with transcript: | 0bp_to_ENSMUST00000144507_5end |
EntrezGene: | Atp2b2 |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
mammary gland | 4.55e-44 | 2 |
external ectoderm | 4.55e-44 | 2 |
mammary bud | 4.55e-44 | 2 |
mammary ridge | 4.55e-44 | 2 |
mammary placode | 4.55e-44 | 2 |
female organism | 3.07e-32 | 11 |
oviduct | 5.07e-23 | 1 |
female reproductive system | 1.01e-10 | 9 |
ectodermal placode | 9.70e-08 | 13 |
adult organism | 1.20e-07 | 51 |